Filing Details
- Accession Number:
- 0001181431-13-064512
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-12-26 08:27:47
- Reporting Period:
- 2013-12-23
- Filing Date:
- 2013-12-26
- Accepted Time:
- 2013-12-26 08:27:47
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 822411 | Immunocellular Therapeutics Ltd. | IMUC | Pharmaceutical Preparations (2834) | 931301885 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1584851 | Anthony Gringeri | 23622 Calabasas Road, Suite 300 Calabasas CA 91302 | Senior Vp Strategic Resources | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-12-23 | 25,000 | $0.00 | 25,000 | No | 4 | P | Indirect | by Trust |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | by Trust |
Footnotes
- The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.8655 to $0.8690.
Billionaire Hedge Funds
